Gastrointestinal carcinoid tumors: Diagnosis and treatment

Chirurgia (Romania)

Volumn 107, Issue 6, 2010, Pages 759-766

  Stamatakos, M ^a   Kontzoglou, K ^a   Sargedi, C ^b   Tsaknaki, S ^a   Iannescu, R ^a   Safioleas, C ^a   Kaitanidi, V ^c   Safioleas, M ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Ystad Hospital   (Sweden)

^c G Gennimatas Hospital   (Greece)

Author keywords

Carcinoid disease; Carcinoid syndrome; Ileal carcinoids; Neuroendocrine cells

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; OCTREOTIDE; TUMOR MARKER;

ABDOMINAL SURGERY; BLOOD; CARCINOID; CARCINOID SYNDROME; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TUMOR; HEALTH; HUMAN; INCIDENCE; METABOLISM; PATHOLOGY; REVIEW; ROMANIA; SMALL INTESTINE; URINE;

ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOID TUMOR; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; INTESTINE, SMALL; MALIGNANT CARCINOID SYNDROME; OCTREOTIDE; ROMANIA; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH;

EID: 84874092848     PISSN: 12219118     EISSN: 1842368X     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Godwin JD. 2nd. Carcinoid tumors. An analysis of 2837 cases. Cancer. 1975;36:560-9.
2. Hatzitheoklitos E, Buchler MW, Friess H, Poch B, Ebert M, Mohr W, et al. Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer. 1994;73: 1580-8. (Pubitemid 24085256)
3. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg. 1998;187:88-92.
4. Lubarsh O. Uber den pimaeren krebs des ileum nebst Bemerkungen ueber das gleichzeitige Vorkommen von krebs und Tuberculos. Virchows Arch. 1888;11:280-317.
5. Oberndorfer S. Uber die 'kleinen Dunndormcarcinome'. Verh Dtsch Ges Pathol. 1907;11:113-6.
6. Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol. 1928; 4:181-212.
7. Cassidy M. Abdominal carcinomatosis associated with vasomotor disturbances. Proc R Soc Med. 1934;27:220-1.
8. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer; 1997;79:813-29. (Pubitemid 27076348)
9. Lu Cortez L, Clemente C, Puig V, Mirada A. Carcinoid tumor. An analysis of 131 cases. Rev Clin Esp. 1994;194:291-3.
10. Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P, et al. The epidemiology of carcinoid tumors in England and Scotland. Br J Cancer. 1994; 70:939-42. (Pubitemid 24331090)
11. Creutzfeldt W. Carcinoid tumors: development of our knowledge. World J Surg. 1996;20:126-31. (Pubitemid 26069476)
12. Neary PC, Redmond PH, Houghton T, Watson GR, Bouchier-Hayes, D. Carcinoid disease: review of the literature. Dis Colon Rectum. 1997;40:349-62. (Pubitemid 27120146)
13. Creutzfeldt W. Historical background and natural history of carcinoids. Digestion. 1994;55(3):3-10.
14. Kloppel G, Heitz PU. Classification of normal and neoplastic neuroendocrine cells. Ann NY Acad Sci. 1994;733:19-23.
15. Wilander E. Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumors. Acta Oncol. 1989;28:363-69. (Pubitemid 19166895)
16. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet. 1998;352:799-805. (Pubitemid 128717532)
17. Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, et al. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Hepatogastroenterology. 2005;52(63):731-41. (Pubitemid 40834594)
18. Calender A. Molecular genetics of neuroendocrine tumors. Digestion. 2000;62(1):3-18. (Pubitemid 30665934)
19. Zirbes TK, Lorenzen J, Baldus SE, Moenig SP, Wolters U, Ottlik A, et al. Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumours of the lung. Histopathology. 1998;33:123-28. (Pubitemid 28387021)
20. Dong Q, Debelenko LV, Chandrasekharappa SC, Emmert-Buck MR, Zhuang Z, Guru SC, et al. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familiar multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1997;82(5):1416-20. (Pubitemid 27200411)
21. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet. 1997;6:2285-90. (Pubitemid 27501081)
22. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954;16:363-71.
23. Sagara M, Sugiyama F, Horiguchi H, Kamma H, Ogata T, Yagami K, et al. Activation of the nuclear oncogenes N-myc and c-jun in carcinoid tumors of transgenic mice carrying the human adenovirus type 12 E1 region gene. DNA Cell Biol. 1995;14:95-101.
24. Warner TF, O'Reilly G, Lee GA. Mesenteric occlusive lesion and ileal carcinoids. Cancer. 1979;44:758-62. (Pubitemid 10233791)
25. Modlin IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol. 2004;99(12):2466-2478. (Pubitemid 40039380)
26. Marshall J, Bodnarchuk G. Carcinoid tumors of the gut: our experience over three decades and review of the literature. J Clin Gastroenterol. 1993;16:123-29. (Pubitemid 23067482)
27. Sakai D, Murakami M, Kawazoe K, Tsutsumi Y. Ileal carcinoid tumor complicating carcinoid heart disease and secondary retroperitoneal fibrosis. Pathol Int. 2000;50(5):404-11. (Pubitemid 30451484)
28. Vinik AI, Thompson N, Eckhauser F, Moattari AR. Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncol. 1989;28:389-402. (Pubitemid 19166900)
29. Davis Z, Moertel CG, McIlarath DC. The malignant carcinoid syndrome. J AM Coll Surg. 1973;137:637-44.
30. Norheim I, Oberg K, Theodorsson-Norheim E, Lindgren PG, Lundqvist G, Magnusson A, et al. Malignant carcinoid tumors: an analysis 103 patients with regard to tumor localization, hormone production and survival. Ann Surg. 1987;206:115-25. (Pubitemid 17104952)
31. Modlin IM, Tang LH. The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology. 1996;111:783-810. (Pubitemid 26293246)
32. Tormey WP, FitzGerald RJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoloceatic acid. Postgrad Med K. 1995;71:542-45.
33. Feldman K, Lee E. Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoloceatic acid. Am J Clin Nutr. 1985;42:639-43. (Pubitemid 15245057)
34. Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E. Clinical significance of blood chromogranin A measurement in neuroendocrine tumors. Ann Oncol. 2001;12:69-72.
35. Zuetenhorst JM, Bonfrer JM, Korse CM, Bakker R, van Tinteren H, Taal BG. Carcinoid heart disease: the role of urinary 5-hydroxyindoloceatic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer. 2003;97:1609-15. (Pubitemid 36350703)
36. Eriksson B, Arnberg H, Lindgren PG, Lörelius LE, Magnusson A, Lundqvist G, et al. Neuroendocrine pancreatic tumors: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med. 1990;228:103-13. (Pubitemid 20257275)
37. Schürmann G, Raeth U, Wiedenmann B, Buhr H, Herfarth C. Serum chromogranin A in the diagnosis and follow up of neuroendocrine tumors of the gastroenteropancreatic tract. World J Surg. 1992;16:697-701.
38. Nehar D, Lombard-Bohas C, Olivieri S, Claustrat B, Chayvialle JA, Penes MC, et al. Interest of chromogranin A for diagnosis and follow up of endocrine tumors. Clin Endocrinol. 2004;60:644-52. (Pubitemid 38669857)
39. Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol. 1997;8:685-90. (Pubitemid 27372168)
40. Modlin I, Lye K, Kidd M. A 5-decade analysis of 13, 715 carcinoid tumors. Cancer. 2003;7:934-59. (Pubitemid 36173145)
41. Gabos S, Berkel J, Robson D, Whittaker, H. Small bowel cancer in Western Canada. Int J Epidemiol. 1993;22:198-206. (Pubitemid 23129319)
42. Burke AP, Thomas RM, Elsayed AM, Sobin LH. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer. 1997;79:1086-93. (Pubitemid 27118204)
43. Feurle GE, Anlauf M, Hamscher G, Arnold R, Kloppel G, Weihe E. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology. 2002;123:1616-26. (Pubitemid 35231661)
44. Stamm B, Hedinger CE, Saremaslani P. Duodenal and ampullary carcinoid tumors: report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN 1 syndrome and von Recklinghausen's disease (neurofibromatosis). Virchows Arch A. 1986;408:475-89. (Pubitemid 16154510)
45. Yamamoto C, Aoyagi K, Suekane H, Iida M, Hizawa K, Kuwano Y, et al. Carcinoid tumors of the duodenum: report of three cases treated by endoscopic resection. Endoscopy. 1997;29:218-21. (Pubitemid 27268190)
46. Clements WM, Martin SP, Stemmerman G, Lowy AM. Ampullary carcinoid tumors: rationale for an aggressive surgical approach. J Gastrointest Surg. 2003;7:773-76. (Pubitemid 37103132)
47. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig E.B. Carcinoid tumors of the duodenum: a clinicopathologic study of 99 cases. Arch Pathol Lab Med. 1990;114:700-704. (Pubitemid 20207048)
48. Lundqvist M, Wilander E. A study of the histopathogenesis of carcinoid tumors of the small intestine and appendix. Cancer. 1987;60:201-6. (Pubitemid 17092257)
49. Cai YC, Barnard G, Hiestand L, Woda B, Colby J, Banner B. Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha. Am J Surg Pathol. 1997;21:1373-77. (Pubitemid 27460864)
50. Cobrin GM, Pittman RH, Lewis BS. Increased diagnostic yield of small bowel tumors with capsule endoscopy. Cancer. 2006;107(1):22-27. (Pubitemid 43939027)
51. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder W, et al. European Neuroendocrine Tumour Society. European Neuro-endocrine Tumor Society. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors. A consensus statement on behalf of the European Neuroendocrine Tumor Society (ENETS). Neuroendocrinology. 2004;80:394-24.
52. Makridis C, Rastad J, Oberg K, Akerstrom G. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World Journal of Surgery. 1996;20: 900-907. (Pubitemid 26281921)
53. Strodel WE, Talpos G, Eckhauser F, Thompson N. Surgical therapy for small-bowel carcinoid tumors. Arch Surg. 1983; 118:391-97. (Pubitemid 13120829)
54. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717-51. (Pubitemid 40692562)
55. Goede AC, Caplin ME, Winslet MC. Carcinoid tumor of the appendix. The British Journal of Surgery. 2003;90:1317-22.
56. Stinner B, Rothmund M. Neuroendocrine tumors (carcinoids) of the appendix. Best Practice & Research. Clinical Gastroenterology. 2005;19:729-38.
57. Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7970 appendectomies. Dis Colon Rectum. 1998;41:75-80. (Pubitemid 28044879)
58. Roggo A, Wood WC, Ottinger LW. Carcinoid tumors of the appendix. Ann Surg. 1993;217:385-90. (Pubitemid 23115342)
59. Shaw PA. The topographical and age distributions of neuroendocrine cells in the normal human appendix. J Pathol. 1991; 164:235-39.
60. Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317:1699-1701. (Pubitemid 18024410)
61. Safioleas MC, Moulakakis KG, Kontzoglou K, Stamoulis J, Nikou GC, Toubanakis C, et al. Carcinoid tumors of the appendix. Prognostic factors and evaluation of indications for right hemicolectomy. Hepatogastroenterology. 2005;52(61): 123-27. (Pubitemid 40282647)
62. Thirlby RC, Kasper CS, Jones RC. Metastatic carcinoid tumor of the appendix: report of a case and review of the literature. Dis Colon Rectum. 1984;27:42-46. (Pubitemid 14217581)
63. Shimizu T, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Sumii K, et al. Growth characteristics of rectal carcinoid tumors. Oncology. 2000;59:229-37.
64. Jetmore AB, Ray JE, Gathright JB, McMullen KM, Hicks TC, Timmcke, AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum. 1992;35:717-25.
65. Onaitis MW, Kirshbom PM, Hayward TZ, Quayle FJ, Feldman JM, Seigler HF, et al. Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann Surg. 2000;232:549-56.
66. Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J Am Coll Surg. 1994;179:231-48. (Pubitemid 24243763)
67. Matsushita M, Takakuwa H, Nishio A. Management of rectal carcinoid tumors. Gastrointest Endosc. 2003;58:641-42.
68. Berkelhammer C, Jasper I, Kirvaitis E, Schreiber S, Hamilton J, Walloch J. 'Band-snare' resection of small rectal carcinoid tumors. Gastrointest Endosc. 1999;50:582-85. (Pubitemid 29480796)
69. Okamoto Y, Fujii M, Tateiwa S, Sakai T, Ochi F, Sugano M, et al. Treatment of multiple rectal carcinoids by endoscopic mucosal resection using a device for esophageal variceal ligation. Endoscopy. 2004;36: 469-70. (Pubitemid 38578906)
70. Loftus JP, van Heerden JA. Surgical management of gastrointestinal carcinoids. Adv Surg. 1995;28:317-36.
71. Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M. Treatment of rectal carcinoid tumors. Am J Surg. 1990;160:262-65. (Pubitemid 20275426)
72. Spread C, Berkel H, Jewell L, Jenkins H, Yakimets W. Colon carcinoid tumors: a population-based study. Dis Colon Rectum. 1994;37:482-91. (Pubitemid 24149685)
73. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM. Gastric carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995; 90:338-52.
74. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World J Surg. 1996;20:168-72. (Pubitemid 26069482)
75. Granberg D, Wilander E, Stridsberg M, Granerus G, Skogseid B, Oberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut. 1998; 43:223-28. (Pubitemid 28348325)
76. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study. Gastroenterology. 1993;104:994-1006. (Pubitemid 23090750)
77. Cadiot G, Laurent-Puig P, Thuille B, Lehy T, Mignon M, Olschwang S. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Elllison syndrome? Gastroenterology. 1993;105:579-82. (Pubitemid 23213547)
78. Wilander E, el-Salhy M, Pitkanen P. Histopathology of gastric carcinoids: A survey of 42 cases. Histopathology. 1984;8:183-93. (Pubitemid 14129002)
79. DeSchtyver-Kecskemeti K, Clouse RE, Kraus FT. Surgical pathology of gastric and duodenal neuroendocrine tumors masquerading as common polyps. Seminars Diagnostic Pathology. 1984;1:5-12. (Pubitemid 14078237)
80. Sjoblom SM. Clinical presentation and prognosis of gastro-intestinal carcinoid tumors. Scand J Gastroenterol. 1988;23: 779-87.
81. Johansson H, Wilander E. A clinical study of 30 gastric carcinoids. Ups J Med Sci. 1982;87:135-42. (Pubitemid 13227153)
82. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology. 1992; 102:1409-18.
83. Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment. Arch Surg. 2001;136:49-54. (Pubitemid 32064120)
84. Gonzalez Ramirez A, Lopez Roses L, Santos Blanco E, Lancho Seco A, Fombella MJ, Garcia-Rodeja E, et al. Multiple gastric carcinoid tumors: Endoscopic management. J Clin Gastroenterol, 1996, 23: pag.75-77. (Pubitemid 26244511)
85. McAleese P, Moorehead J. Multiple gastric carcinoid tumors in a patient with pernicious anaemia: Endoscopic removal or gastric resection? Eur J Surg. 1994;160:243-46. (Pubitemid 24156636)
86. Ichikawa J, Tanabe S, Koizumi W, Kida Y, Imaizumi H, Kida M, et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy. 2003; 35:203-206. (Pubitemid 36292294)
87. Kern SE, Yardley JH, Lazenby AJ, Boitnott JK, Yang VW, Bayless TM, et al. Reversal by antrectomy of endocrine cell hyperplasia in the gastric body in pernicious anemia: A morphometric study. Mod Pathol. 1990;3:561-66.
88. Higham AD, Dimaline R, Varro A, Attwood S, Armstrong G, Dockray GJ, et al. Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology. 1998;114:817-22. (Pubitemid 28160417)
89. Moriyama T, Matsumoto T, Hizawa K, Esaki M, Lwai K, Yao T, et al. A case of multicentric gastric carcinoids without hypergastrinemia. Endoscopy. 2003;35:86-88. (Pubitemid 36131257)
90. Otani Y, Furukawa T, Suganuma K, Yoshida M, Saikawa Y, Kubota T, et al. Minimally invasive surgery for gastric carcinoid tumor. Biomed Pharmacother. 2002;56:217-21.
91. Griffin M, Sweeney EC. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the esophagus. Histopathology. 1987;11: 53-62. (Pubitemid 17024335)
92. Lindberg GM, Molberg KH, Vuitch MF, Albores-Saavedra J. Atypical carcinoid of the esophagus: a case report and review of the literature. Cancer. 1997;79:1476-81. (Pubitemid 27154775)
93. Mehta DC, Warner RR, Parnes I, Weiss M. An 18-year follow-up of primary hepatic carcinoid with carcinoid syndrome. J Clin Gastroenterol. 1996;23:60-62. (Pubitemid 26244505)
94. Ross AC, Hurley JB, Hay WB, Rusnak CH, Petrunia DM. Carcinoids of the common bile duct: a case report and literature review. Can J Surg. 1999;42:59-63. (Pubitemid 29095680)
95. Chamberlin RS, Blumgart LH. Carcinoid tumors of the extrahepatic bile duct: a rare cause of malignant biliary obstruction. Cancer. 1999;86:1959-65.
96. Z'graggen K, Birrer S, Maurer CA, Klaiber C, Baer HU. Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma. Surgery. 1998;124:831-38. (Pubitemid 28520774)
97. Nies C, Zielke A, Hasse C, Ruschoff J, Rothmund M. Carcinoid tumors of Meckel's diverticula. Report of two cases and review of the literature. Dis. Colon Rectum. 1992;35:589-96.
98. Koch CA, Azumi N, Furlong MA, Jha RC, Kehoe TE, Trowbridge CH, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999;84:4209-13. (Pubitemid 30644219)